The inflammasome regulatory pathway and infections: role in pathophysiology and clinical implications

R Osawa, KL Williams, N Singh - Journal of infection, 2011 - Elsevier
The innate immune system serves to generate immediate host defenses against pathogens.
Advance in the mechanism of innate immunity has provided new insights into host-pathogen …

Pneumonia in a patient with familial Mediterranean fever successfully treated with anakinra—case report and review

S Hennig, K Bayegan, M Uffmann… - Rheumatology …, 2012 - Springer
We report the case of a 35-years-old renal transplant patient known to have familial
Mediterranean fever with serum amyloid A (SAA)-amyloidosis, who presented with his …

Autoinflammatory syndromes for the dermatologist

P Dávila-Seijo, A Hernández-Martín, A Torrelo - Clinics in Dermatology, 2014 - Elsevier
While autoimmunity as cause of disease is well-established, other categories of immune-
mediated diseases that are not produced by targeting of self-antigens by antibodies is in the …

Non‐response to colchicine in familial Mediterranean fever should be identified accurately

MA Melikoglu, K Senel - International Journal of Rheumatic …, 2017 - Wiley Online Library
Aim Colchicine prophylaxis is the single most important factor in ameliorating familial
Mediterranean fever (FMF) for the prevention of both attacks and secondary amyloidosis …

Fevers, genes, and innate immunity

JG Ryan, DL Kastner - Immunology, Phenotype First: How Mutations Have …, 2008 - Springer
The characterization of patients with recurrent inflammatory syndromes into distinct clinical
phenotypes provided early clues to the mode of inheritance of these conditions and …

IL-1 as a target in inflammation

Y Ito, N Kaneko, T Iwasaki, S Morikawa… - … Metabolic & Immune …, 2015 - ingentaconnect.com
Inflammation is a protective response to eliminate cytotoxic agents and pathogens. Various
factors are thought to be involved in the pathological changes in tissues caused by …

Transmission of familial Mediterranean fever mutation after bone marrow transplantation and successful treatment with anakinra

AD Petropoulou, M Robin, G Socié, L Galicier - Transplantation, 2010 - journals.lww.com
Furthermore, 10% of patients are unresponsive to colchicine (10). Recent short reports
demonstrate the efficacy of IL-1 receptor antagonist therapy (anakinra) in colchicine …

When to suspect autoinflammatory/recurrent fever syndromes

JW Verbsky - Pediatric Clinics, 2017 - pediatric.theclinics.com
Inflammation, the classic quadrad of “rubor (redness), tumor (swelling), calor (heat), and
dolor (pain)”, is a fundamental concept of immunology and a common observation in clinical …

Canakinumab investigated for treating familial Mediterranean fever

R Haviv, PJ Hashkes - Expert opinion on biological therapy, 2016 - Taylor & Francis
ABSTRACT Introduction: Familial Mediterranean fever (FMF) is the most common hereditary
autoinflammatory syndrome. The treatment of choice is colchicine. However,~ 40% of …

[PDF][PDF] Paediatric rheumatology Development of a medication adherence scale for familial Mediterranean fever (MASIF) in a cohort of Turkish children

S Yesilkaya, C Acikel, BE Fidanci, A Polat… - Clin Exp …, 2015 - researchgate.net
Objective. To develop and assess the validity and reliability of an adherence scale
concerning medical treatment in paediatric FMF patients. Methods. The Medication …